1 / 10

Blood-brain barrier

Blood-brain barrier. Karl Kristinsson, 5. árs læknanemi. Samsetning. Blood-brain barrier (BBB) er nauðsynlegur fyrir eðlilega virkni miðtaugakerfis BBB: Endothel frumur með þétt-tengi (tight junctions) Astrocytar Pericytar.

gracie
Télécharger la présentation

Blood-brain barrier

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Blood-brain barrier Karl Kristinsson, 5. árs læknanemi

  2. Samsetning • Blood-brain barrier (BBB) er nauðsynlegur fyrir eðlilega virkni miðtaugakerfis • BBB: • Endothel frumur með þétt-tengi (tight junctions) • Astrocytar • Pericytar • BBB er að finna alls staðar í heilanum nema í s.k. circumventriuclar organs (area postrema, neurohypophysis ofl.)

  3. Plexus choroideus • Blóð flæðir um microvilli og heila- og mænuvökvi (HMV) myndast • Hlutverk HMV er að næra og hreinsa niðurbrotsefni • Epithel frumur plexus choroideus hafa þétt-tengi • Flæðir treglega inn en auðveldlega út

  4. Eiginleikar

  5. Spilað á BBB • Lyf tengd við albúmín, insúlín eða fjölstofna mótefni • Mannitól opnar BBB • Afturkræft • ↓ system áhrif

  6. Spilað á BBB • Trans-nasal lyfjagjöf á litlum fituleysanlegum sameindum • Intraventricular/intra-cerebral gjöf

  7. BBB og sýkingar • Meningococcar og S. pneumoniae hafa sækni í endothel frumur í heila • Pneumococcar stuðla að losun IL-1, TNF og metallópróteinasa sem rjúfa BBB • Sýklalyf eiga þá greiðari aðgang að MTK • Barksterar koma BBB aftur á og geta minnkað fylgikvilla (H. influenzae meningitis)

  8. “...in fact, there is not a single medium or large pharmaceutical company in the world today that has a BBB-drug-targeting technology program.” -William M. Pardridge, janúar 2007

  9. Takk fyrir ...spurningar?

  10. Heimildir • Ballabh, P et. al: The blood-brain barrier: an overview. Structure, regulation, and clinical implications. Neurobiology of disease 16:1-13. 2004 • Neuwelt, EA: Mechanism of disease: The blood-brain barrier. Neurosurgery 54:131-142. 2003. • Pardridge, WM: Blood-brain barrier delivery. Drug discovery today 12:54-61. 2007. • Up To Date online: www.utdol.com

More Related